Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell‐Based Treatments

Subretinal delivery of stem cell‐derived retinal cells as a strategy to treat retinal degenerative blindness holds great promise. Currently, two clinical trials are underway in which human fetal retinal progenitor cells (RPCs) are being delivered to patients by intravitreal or subretinal injection t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Scruggs, Brittni A., Jiao, Chunhua, Cranston, Cathryn M., Kaalberg, Emily, Wang, Kai, Russell, Stephen R., Wiley, Luke A., Mullins, Robert F., Stone, Edwin M., Tucker, Budd A., Sohn, Elliott H.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Standards, Protocols, Policies, and Regulations for Cell‐Based Therapies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646699/
https://ncbi.nlm.nih.gov/pubmed/31004408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados